Is the Calquence Market Redefining Targeted Cancer Therapy Worldwide?

a adăugat un sunet Alte

2026-02-26 10:11:46 -

Calquence Market growth reflects the accelerating shift toward precision oncology treatments. The Calquence (acalabrutinib) market was valued at USD 2.5 Billion in 2023 and is projected to reach USD 20.6 Billion by 2030, registering a strong CAGR of 21.3% from 2024 to 2034. This rapid expansion highlights rising adoption of next-generation BTK inhibitors for hematologic malignancies. Clinical...

0 Commentarii 0 Distribuiri 158 Views 0 previzualizare